US Stock MarketDetailed Quotes

SABS SAB Biotherapeutics

Watchlist

2.4000
-0.0700-2.83%

Trading Oct 15 15:52 ET

22.15MMarket Cap-389P/E (TTM)

SAB Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

SAB Biotherapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 120.000K	--
--	2024/Q3	-- / 120.000K	--
--	2024/Q2	263.140K / 0.000	--
--	2024/Q1	944.580K / 0.000	--
--	2023/Q4	305.010K / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 120.000K--

--2024/Q3-- / 120.000K--

--2024/Q2263.140K / 0.000--

--2024/Q1944.580K / 0.000--

--2023/Q4305.010K / 0.000--

Unlock Free Earnings Estimates

Open Account

SAB Biotherapeutics Earnings Reports

10-Q: Q2 2024 Earnings Report

Aug 8 16:37 ET

10-Q: Q1 2024 Earnings Report

May 20 16:06 ET

SAB Biotherapeutics | 10-K: FY2023 Annual Report

Mar 29 13:23 ET

SAB Biotherapeutics | 10-Q: Q3 2023 Earnings Report

Nov 13, 2023 16:48 ET

Analyst Rating

Updated: Oct 9, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall